BioAccel is a unique, fully independent, non-profit organization created to provide funding and business expertise to develop early stage life science technologies that drive local economic development efforts. By filling the early funding and expertise gaps and “Living in the Valley of Death,” BioAccel accelerates the development of new companies, drives economic development, and creates new biomedical products, which over time will become available to the general public. BioAccel has identified four resource areas that must be available and integrated to ensure the successful journey of research discoveries efficiently down the commercialization path: Identification and access to intellectual property and novel ideas Financial capital that includes proof of concept, seed and venture Business, technical and regulatory expertise A network of experienced and knowledgeable mentors and advisors
Life365, Inc. is a provider of a virtual care and remote patient monitoring platform designed to enhance patient engagement and reduce healthcare costs. Based in Scottsdale, Arizona, the company offers Life365 Kits, which comprise pre-paired and pre-configured smart devices, along with non-connected options, to facilitate health data collection outside traditional care settings. Its platform functions as a Digital Health as a Service (DHaaS), integrating various tools and devices to connect care providers with patients, particularly benefiting those managing health conditions at home. Life365's solutions are tailored for Accountable Care Organizations, insurers, and home healthcare services, utilizing its proprietary Personalyze™ Engagement Analytics Engine to maximize user engagement and adoption. With a focus on moving care delivery from clinics to homes, Life365 aims to gather patient data economically, ultimately improving health outcomes while lowering costs associated with healthcare delivery. The company was incorporated in 2015 and has played a significant role in advancing remote care technology.
Yolia Health, based in Mexico City, specializes in developing medical equipment aimed at preserving, restoring, and enhancing vision. The company has created The True Vision Treatment (TVT), a non-invasive solution designed to correct vision problems such as presbyopia without the need for surgery. This innovative treatment allows patients to self-administer care at home using customized contact lenses and specially formulated eye drops. After just five days of treatment, patients can discontinue the use of both the TVT products and reading glasses for up to 12 months before requiring re-treatment. Notably, Yolia's approach not only corrects near vision but also improves distance vision, distinguishing it from other alternatives in the market. The company is actively seeking sophisticated investors and key industry partners to further its mission.
Arizona Medical Systems, LLC (AMS) is a medical device company established through a collaboration involving Dr. Richard Heuser, MediCoventures, and BioAccel. The company focuses on developing innovative technologies to enhance medical procedures, particularly in the field of vascular access. Its flagship product, the Punctual Guidewire™, aims to streamline the process of obtaining rapid vascular access for physicians, ultimately leading to improved patient outcomes. By addressing key issues such as waste reduction, cost minimization, and decreased blood loss associated with traditional vascular access methods, AMS positions itself to meet the growing demand for advanced cardiovascular technologies.
Omni Bioceutical Innovations is committed to delivering innovative skin treatment and care solutions to meet the dermatological needs of people throughout their lifetime while serving professionals in the global medical aesthetic market.
Supported by an extraordinary collaboration of scientists, forward-thinking physicians, and labs, Omni produces superior growth factor proteins, amino acids, peptides, and unique formulas for use in skin and hair products.
It was founded in 2014 and is headquartered in Phoenix, Arizona.
Yolia Health, based in Mexico City, specializes in developing medical equipment aimed at preserving, restoring, and enhancing vision. The company has created The True Vision Treatment (TVT), a non-invasive solution designed to correct vision problems such as presbyopia without the need for surgery. This innovative treatment allows patients to self-administer care at home using customized contact lenses and specially formulated eye drops. After just five days of treatment, patients can discontinue the use of both the TVT products and reading glasses for up to 12 months before requiring re-treatment. Notably, Yolia's approach not only corrects near vision but also improves distance vision, distinguishing it from other alternatives in the market. The company is actively seeking sophisticated investors and key industry partners to further its mission.
Hildeez Enterprises
Non Equity Assistance in 2015
Hildeez Enterprises is a manufacturer of post-surgical recovery garments intended for patients who undergo surgical procedures of the knee, hip, or shoulder. The recovery garments provide modesty for patients in a hospital setting instead of having to 'bear it all' using the traditional gowns. The company was founded in 2010 and based in Peoria, Arizona.
Verve Medical, Inc. is an early-stage medical device company committed to developing novel, trans- urethral, natural orifice, Renal Denervation devices to ameliorate treatment-resistant hypertension and associated diseases for the benefit of patients world-wide.
Nasseo, Inc. is a medical device company based in Peoria, Arizona, specializing in the development and manufacturing of dental and orthopedic implant systems. Established in 2012, Nasseo focuses on providing innovative treatment options for patients with circulatory issues, such as diabetics and smokers. The company has pioneered a next-generation nanotube implant surface technology known as TiArray, which enhances the bonding and healing processes of implants. This technology modifies the natural oxide layer of various implant materials to create a uniform nanotube array, resulting in improved anti-inflammatory, anti-bacterial properties, and better soft tissue responses. Nasseo's first product, the TiArray Dental Implant, has received FDA approval, and the company plans to conduct post-market human clinical trials. Additionally, Nasseo is in the development phase of a Titanium-PEEK hybrid interbody fusion device that will also utilize TiArray technology, further expanding its product offerings in the medical device market.
RightBio Metrics Inc. specializes in fluid measurement technologies aimed at healthcare providers, primarily focusing on gastric pH measurement devices. The company offers several innovative products, including RightpH, which assists clinicians with critical decision-making regarding tube placement in critically ill patients; RightSpot, a non-invasive diagnostic device for verifying gastric acidity to prevent the misplacement of feeding and suction tubes; and RightLevel, which provides real-time pH readings to clinicians. Additionally, RightSpot Infant is tailored for measuring gastric acidity in infants. Founded in 2005 and based in Scottsdale, Arizona, RightBio Metrics enhances the speed and quality of medical treatment by enabling healthcare professionals to make informed decisions based on accurate biofluid measurements.
TinyKicks is a technology company. It develops a wireless smart sensor system that captures fetal movement with machine learning to predict and guide healthy pregnancy outcomes. The company provides TinyKicks eMotion fetal activity monitor, a wearable band aid that senses the users baby kicks, and separates the baby’s kicks from its user’s own movements. The kicks are monitored continuously and the information is uploaded automatically to the user’s smartphone. TinyKicks was founded by France Helfer in 2014 and is headquartered in Irvine, California.
MyFuelUp is a FREE web/mobile application providing nutrient-timed, flexible meal planning in support of YOUR body, lifestyle, and health/fitness goal. Our mission is "to empower people to make the most effective and efficient daily nutritional decisions through mobile technology." From converting the generated diet into an organized grocery list and selecting products available where you shop, to providing menu recommendations at local restaurants - MyFuelUp puts you in the driver's seat to attaining your health and fitness goal.
Nasseo, Inc. is a medical device company based in Peoria, Arizona, specializing in the development and manufacturing of dental and orthopedic implant systems. Established in 2012, Nasseo focuses on providing innovative treatment options for patients with circulatory issues, such as diabetics and smokers. The company has pioneered a next-generation nanotube implant surface technology known as TiArray, which enhances the bonding and healing processes of implants. This technology modifies the natural oxide layer of various implant materials to create a uniform nanotube array, resulting in improved anti-inflammatory, anti-bacterial properties, and better soft tissue responses. Nasseo's first product, the TiArray Dental Implant, has received FDA approval, and the company plans to conduct post-market human clinical trials. Additionally, Nasseo is in the development phase of a Titanium-PEEK hybrid interbody fusion device that will also utilize TiArray technology, further expanding its product offerings in the medical device market.
Stimwave LLC is a medical device company focused on developing, manufacturing, and marketing wireless microsize injectable devices for neurology applications. The company's product offerings include the Freedom SCS System, a spinal cord stimulator designed to alleviate chronic low back and leg pain, and the StimQ PNS System, a peripheral nerve stimulator that addresses chronic pain by targeting specific peripheral nerves. Originally incorporated as Neural Micro Incorporated in 2010, Stimwave LLC is headquartered in Pompano Beach, Florida.